MAPT and Neurodevelopmental delay: Similarly, antibodies and aptamers binding other pathogenic proteins such as Alpha-syn, Tau, TDP43, or mutant HTT might be of interest to treat other NDD via the pseudodelivery route, even if they failed when systemically administered for safety or efficacy reasons [58,85,86,96,97,103,105,115].